Research
Mayo Clinic researchers report encouraging early results from an experimental therapy targeting the genetic cause of a rare form of amyotrophic lateral sclerosis, or ALS.
Latest stories
Research
March 24, 2025
Individualized Medicine
March 18, 2025
Healthcare Delivery
March 12, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community